| 1 | 3 mg [14C]-A4250 capsule | - | - | - | - | [3] 93 93, 297, 338 💬
|
| 2 | [A4250] | - | - | - | - | [3] 296 296, 297, 338 💬
|
| 3 | A4250 | - | - | - | - | [4] 93 93, 296, 297, 338 💬
|
| 4 | A4250-015 | - | - | - | - | [1] 297 297 💬
|
| 5 | Atorvastatin | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [21] 13 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
|
| 6 | CRC (A3384) | - | - | - | - | [3] 93 93, 297, 338 💬
|
| 7 | Livmarli | - | - | - | - | [2] 297 297, 338 💬
|
| 8 | Livmarli Oral Product | - | - | - | - | [2] 297 297, 338 💬
|
| 9 | LUM001 | - | - | - | - | [4] 93 93, 94, 297, 338 💬
|
| 10 | LUM001 (Maralixibat) | [1] Maralixibat Maralixibat | [2] Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| [2] SLC10A1 SLC10A1, SLC10A2 💬
| [3] Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | [2] 297 297, 338 💬
|
| 11 | Magnesium | [1] Magnesium Magnesium | - | - | - | [23] 3 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
|
| 12 | Magnesium gluconate | [2] Magnesium Magnesium, Magnesium gluconate | [1] Magnesium gluconate
Magnesium gluconate
💬
| - | - | [2] 296 296, 297 💬
|
| 13 | Magnesium sulfate | [2] Magnesium Magnesium, Magnesium sulfate | [1] Magnesium sulfate
Magnesium sulfate
💬
| - | - | [4] 11 11, 97, 296, 297 💬
|
| 14 | Maralixibat | [1] Maralixibat Maralixibat | [2] Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| [2] SLC10A1 SLC10A1, SLC10A2 💬
| [3] Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | [4] 296 296, 297, 299, 338 💬
|
| 15 | Maralixibat (formely SHP625 or LUM001) | [1] Maralixibat Maralixibat | [2] Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| [2] SLC10A1 SLC10A1, SLC10A2 💬
| [3] Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | [3] 296 296, 297, 338 💬
|
| 16 | Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 5-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 10-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 15-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 20- | [1] Maralixibat Maralixibat | [2] Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| [2] SLC10A1 SLC10A1, SLC10A2 💬
| [3] Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | [3] 296 296, 297, 338 💬
|
| 17 | MARALIXIBAT CHLORIDE | [1] Maralixibat Maralixibat | [2] Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| [2] SLC10A1 SLC10A1, SLC10A2 💬
| [3] Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | [3] 296 296, 297, 338 💬
|
| 18 | Odevixibat | [1] Odevixibat Odevixibat | [2] Odevixibat
Odevixibat
,
Odevixibat hydrate
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [3] 296 296, 297, 338 💬
|
| 19 | OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 200-Product Name: OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 400-Product Name: OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 600-Product Name: OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 1200- | - | - | - | - | [1] 297 297 💬
|
| 20 | Questran | - | - | - | - | [4] 93 93, 254, 297, 338 💬
|
| 21 | TAK-625 | - | - | - | - | [2] 297 297, 338 💬
|